Medall Scans And Labs Marthahalli Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 4.25 M
as on 04-07-2024
- Paid Up Capital ₹ 4.25 M
as on 04-07-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -6.19%
(FY 2020)
- Profit -2867.74%
(FY 2020)
- Ebitda -147.55%
(FY 2020)
- Net Worth -25.57%
(FY 2020)
- Total Assets 7.96%
(FY 2020)
About Medall Scans And Labs Marthahalli
The Corporate was formerly known as Medall Scans And Labs Erode Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.25 M and a paid-up capital of Rs 4.25 M, as per Ministry of Corporate Affairs (MCA) records.
Yogeshwaran Nagarajan, Madan Babu, Thulasiram Kesavan, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900TN2011PTC080255
- Company No.
080255
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Medall Scans And Labs Marthahalli?
Board Members(4)
Financial Performance and Corporate Structure Insights of Medall Scans And Labs Marthahalli.
Medall Scans And Labs Marthahalli Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 6.19% decrease. The company also saw a substantial fall in profitability, with a 2867.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medall Scans And Labs Marthahalli?
In 2020, Medall Scans And Labs Marthahalli had a promoter holding of 76.47% and a public holding of 23.53%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medall Spark Diagnostics Nashik Private Limited
Active
11 years 4 months Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Clumax Diagnostic And Research Centre Private Limited
Active 19 years 10 months Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Medall Scans And Labs Ranchi Private Limited
Active 9 years 3 months Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Medall Visakhapatnam Private Limited
Active 5 years 10 months Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medall Scans And Labs Marthahalli?
Unlock and access historical data on people associated with Medall Scans And Labs Marthahalli, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Apr 23, 2015, Medall Scans And Labs Marthahalli has raised a total of ₹ 2.49 Cr, with the most recent deal valued at ₹ 1.89 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
